BRAIN Biotech AG (BNN.DE) Stock Price
€2.09 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on BRAIN Biotech AG, AI stock picks, stock alerts and much more.
BNN.DE AI Stock Analysis
AI stock analysis for BNN.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BRAIN Biotech AG (BNN.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BRAIN Biotech AG (BNN.DE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BRAIN Biotech AG (BNN.DE), currently trading at €2.09, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BNN.DE
-
BRAIN Biotech AG researches, develops, produces, and markets enzymes, biocatalysts, microorganisms, and bioactive natural substances for chemical industries in Germany, the United States, France, the Netherlands, and the United Kingdom.
-
Symbol
BNN.DE
-
Market
XETRA
-
Industry
Biotechnology
-
Market Cap
45.7M
Similar Stocks
 |
CureVac 5CV.F |
€4.64 1% |
5 |
 |
BioNTech SE 22UA.F |
€95.8 0.2% |
5 |
 |
Novavax NVV1.F |
€6.74 1.8% |
3 |
 |
Heidelberg Pharma AG HPHA.DE |
€4.38 1.4% |
7 |
 |
Formycon AG FYB.DE |
€24.5 1.5% |
6 |
News
BNN.DE Alternative Data
Web Traffic
BRAIN Biotech AG receives an estimated 1290 monthly visitors to brain-biotech.com.
-
Web Traffic
1290
-
Change from Previous Month
53.4%
-
3 Month Change
26.8%
-
YoY Change
26.8%
Twitter Followers
BRAIN Biotech AG has 815 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
815
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.2%
Youtube Subscribers
BRAIN Biotech AG has 113 subscribers on its main Youtube channel, up by 0.9% over the last month.
-
Youtube Subscribers
113
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
0%
Job Postings
BRAIN Biotech AG currenly has an estimated 1 open job postings.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
66.7%
LinkedIn Followers
8,807 are following BRAIN Biotech AG on LinkedIn, up by 1.3% over the last month.
-
LinkedIn Followers
8807
-
Daily Change
1.3%
-
1 Month Change
1.3%
-
3 Month Change
4.7%
LinkedIn Employees
According to LinkedIn, BRAIN Biotech AG has 179 employees, up by 0.6% over the last month.
-
LinkedIn Employees
179
-
Daily Change
0.6%
-
1 Month Change
0.6%
-
3 Month Change
1.1%
Reddit Mentions
BRAIN Biotech AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
BRAIN Biotech AG was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
BNN.DE Financials
BNN.DE Key Metrics
-
Total Revenue
€13.1M
-
Net Income
-€4M
-
Earnings per Share
-€0.18
-
Free cash flow
-€3.3M
-
EBITDA
-€1.6M
-
EBITDA Ratio
-0.118782
-
Total Assets
€80.3M
BNN.DE 2-year Revenue & Income
BNN.DE 2-year Free Cash Flow
BNN.DE Technicals
BNN.DE SMA
BNN.DE RSI
FAQ
What's the current price of BRAIN Biotech AG (BNN.DE) Stock?
The price of an BRAIN Biotech AG (BNN.DE) share is €2.09.
What's the market cap of BRAIN Biotech AG?
The current market cap of BRAIN Biotech AG is 45.7M.
Should I buy or sell BNN.DE?
BRAIN Biotech AG shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, BRAIN Biotech AG is better viewed as a hold or accumulate position while waiting for further developments.
Is BRAIN Biotech AG a good investment?
The current analysis of BRAIN Biotech AG's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in BRAIN Biotech AG's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy BRAIN Biotech AG (BNN.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for BRAIN Biotech AG stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to BRAIN Biotech AG (BNN.DE) that investors often compare it to?
BRAIN Biotech AG (BNN.DE) is often compared to similar stocks such as CureVac, BioNTech SE, Novavax, Heidelberg Pharma AG and Formycon AG.
What is the forecast for BRAIN Biotech AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BRAIN Biotech AG's stock price to be around €2 in 2026. Starting from the current price of €2.09, this represents a 4.4% change in price, indicating a bearish outlook for the stock.
How to buy BRAIN Biotech AG (BNN.DE) Stock?
BRAIN Biotech AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BRAIN Biotech AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.